Urinary thromboxane B2 and thromboxane receptors in bladder cancer: Opportunity for detection and monitoring

We have previously found increased expression of thromboxane synthase (TXAS) and thromboxane receptor (TP) beta isoform in the tissues of patients with bladder cancer. Studies in cell lines and mice have indicated a potential significant role of the thromboxane signaling pathway in the pathogenesis of human bladder cancer. This study was designed to determine if the changes observed in the tissues of patients with bladder cancer were mirrored by changes in the urine of these patients. We found increased levels of thromboxane B2 (TXB2) the major metabolite of TXAS and increased levels of the TPβ receptor. These results raised the possibility that patients with bladder cancer may be followed for progression or remission of their disease by quantitation of these substances in their urine.

► Increased urinary levels of thromboxane B2 in bladder cancer patients.
► Increased urinary levels of thromboxane receptor beta isoform in bladder cancer patients.
► Potential non-invasive diagnostic and prognostic test for bladder cancer.